Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


19.04.2021

3 AJR Am J Roentgenol
1 Ann Surg Oncol
1 Anticancer Res
4 BMC Cancer
4 Br J Cancer
1 Breast Cancer
1 Breast Cancer Res Treat
1 Cancer Lett
1 Eur J Cancer
18 Eur Radiol
2 Int J Cancer
4 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
2 J Surg Oncol
3 Lancet Oncol
1 Oncogene
2 Oncol Rep
1 Radiol Imaging Cancer
2 Radiology
9 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. NEAL CH, Joe AI, Patterson SK, Pujara AC, et al
    Digital Mammography Has Persistently Increased High-Grade and Overall DCIS Detection Without Altering Upgrade Rate.
    AJR Am J Roentgenol. 2021 Feb 17:1-7. doi: 10.2214/AJR.20.23314.
    PubMed         Abstract available

  2. EGHTEDARI M, Chong A, Rakow-Penner R, Ojeda-Fournier H, et al
    Current Status and Future of BI-RADS in Multimodality Breast Imaging, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.24894.
    PubMed         Abstract available

  3. GRIMM LJ, Neely B, Hou R, Selvakumaran V, et al
    Mixed-methods study to predict upstaging of DCIS to invasive disease on mammography.
    AJR Am J Roentgenol. 2020 Aug 12. doi: 10.2214/AJR.20.23679.
    PubMed         Abstract available


    Ann Surg Oncol

  4. GOMMERS JJJ, Duijm LEM, Voogd AC
    ASO Author Reflections: Impact of Preoperative MRI on Patients With Screen-Detected Invasive Breast Cancer Undergoing Breast-Conserving Surgery.
    Ann Surg Oncol. 2021 Apr 11. pii: 10.1245/s10434-021-09936.
    PubMed        


    Anticancer Res

  5. NIEDER C, Mannsaker B, Yobuta R
    Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases.
    Anticancer Res. 2021;41:1471-1474.
    PubMed         Abstract available


    BMC Cancer

  6. ZHONG L, Xie L, Yang Z, Li L, et al
    Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
    BMC Cancer. 2020;20:766.
    PubMed         Abstract available

  7. ALEXEEV SM, Khorinko AV, Mukhametshina GZ, Shelepen KG, et al
    Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab.
    BMC Cancer. 2020;20:783.
    PubMed         Abstract available

  8. HICKS BM, Busby J, Mills K, O'Neil FA, et al
    Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.
    BMC Cancer. 2020;20:804.
    PubMed         Abstract available

  9. YANG H, Xu Y, Zhao Y, Yin J, et al
    The role of tissue elasticity in the differential diagnosis of benign and malignant breast lesions using shear wave elastography.
    BMC Cancer. 2020;20:930.
    PubMed         Abstract available


    Br J Cancer

  10. JAYARAJ R, Shaw P, Shetty S, Kumaraswamy C, et al
    Comment on "Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis".
    Br J Cancer. 2021 Apr 12. pii: 10.1038/s41416-021-01348.
    PubMed        

  11. CHEN JY, Li CF, Lai YS, Hung WC, et al
    Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth.
    Br J Cancer. 2021;124:484-493.
    PubMed         Abstract available

  12. DAVE RV, Kim B, Courtney A, O'Connell R, et al
    Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.
    Br J Cancer. 2021 Apr 12. pii: 10.1038/s41416-021-01378.
    PubMed        

  13. OTSUJI K, Sasaki T, Tanabe M, Seto Y, et al
    Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
    Br J Cancer. 2021;124:466-473.
    PubMed         Abstract available


    Breast Cancer

  14. NAGASAKI E, Kudo R, Tamura M, Hayashi K, et al
    Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report.
    Breast Cancer. 2021 Apr 11. pii: 10.1007/s12282-021-01240.
    PubMed         Abstract available


    Breast Cancer Res Treat

  15. PAI T, Cornell L, Seneviratne D, Niazi S, et al
    Pre-diagnosis major life stressors and breast cancer outcomes.
    Breast Cancer Res Treat. 2021 Apr 12. pii: 10.1007/s10549-021-06218.
    PubMed         Abstract available


    Cancer Lett

  16. VENKATESH J, Wasson MD, Brown JM, Fernando W, et al
    LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
    Cancer Lett. 2021 Apr 10. pii: S0304-3835(21)00156.
    PubMed         Abstract available


    Eur J Cancer

  17. PATRIKIDOU A, Cathomas R
    Treading carefully in de-escalation for bone-targeted agents - is less more, after all?
    Eur J Cancer. 2021;142:141-142.
    PubMed        


    Eur Radiol

  18. GOH Y, Chan CW, Pillay P, Lee HS, et al
    Architecture distortion score (ADS) in malignancy risk stratification of architecture distortion on contrast-enhanced digital mammography.
    Eur Radiol. 2021;31:2657-2666.
    PubMed         Abstract available

  19. LO GULLO R, Daimiel I, Rossi Saccarelli C, Bitencourt A, et al
    Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers.
    Eur Radiol. 2020;30:6721-6731.
    PubMed         Abstract available

  20. DONG Y, Liu Y, Chen J, Li W, et al
    Comparison of postoperative CT- and preoperative MRI-based breast tumor bed contours in prone position for radiotherapy after breast-conserving surgery.
    Eur Radiol. 2021;31:345-355.
    PubMed         Abstract available

  21. NISSAN N, Sandler I, Eifer M, Eshet Y, et al
    Physiologic and hypermetabolic breast 18-F FDG uptake on PET/CT during lactation.
    Eur Radiol. 2021;31:163-170.
    PubMed         Abstract available

  22. DAIMIEL NARANJO I, Lo Gullo R, Saccarelli C, Thakur SB, et al
    Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
    Eur Radiol. 2021;31:356-367.
    PubMed         Abstract available

  23. REBELLA G, Romano N, Silvestri G, Ravetti JL, et al
    Calcified brain metastases may be more frequent than normally considered.
    Eur Radiol. 2021;31:650-657.
    PubMed         Abstract available

  24. LUCIONI M, Rossi C, Lomoro P, Ballati F, et al
    Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
    Eur Radiol. 2021;31:920-927.
    PubMed         Abstract available

  25. MOLLOI S, Ding H, Cho HM, Beidokhti D, et al
    Quantification of water and lipid density with dual-energy mammography: validation in postmortem breasts.
    Eur Radiol. 2021;31:938-946.
    PubMed         Abstract available

  26. HU Y, Zhan C, Yang Z, Zhang X, et al
    Accelerating acquisition of readout-segmented echo planar imaging with a simultaneous multi-slice (SMS) technique for diagnosing breast lesions.
    Eur Radiol. 2021;31:2667-2676.
    PubMed         Abstract available

  27. MONTEMEZZI S, Cardano G, Storer S, Cardobi N, et al
    MRI-guided breast biopsy based on diffusion-weighted imaging: a feasibility study.
    Eur Radiol. 2021;31:2645-2656.
    PubMed         Abstract available

  28. MA Y, Liu A, O'Connell AM, Zhu Y, et al
    Contrast-enhanced cone beam breast CT features of breast cancers: correlation with immunohistochemical receptors and molecular subtypes.
    Eur Radiol. 2021;31:2580-2589.
    PubMed         Abstract available

  29. CHOI WJ, Han K, Shin HJ, Lee J, et al
    Calcifications with suspicious morphology at mammography: should they all be considered with the same clinical significance?
    Eur Radiol. 2021;31:2529-2538.
    PubMed         Abstract available

  30. PARK KW, Park S, Shon I, Kim MJ, et al
    Non-mass lesions detected by breast US: stratification of cancer risk for clinical management.
    Eur Radiol. 2021;31:1693-1706.
    PubMed         Abstract available

  31. LANG K, Dustler M, Dahlblom V, Akesson A, et al
    Identifying normal mammograms in a large screening population using artificial intelligence.
    Eur Radiol. 2021;31:1687-1692.
    PubMed         Abstract available

  32. AVENDANO D, Marino MA, Onishi N, Leithner D, et al
    Can Follow-up be Avoided for Probably Benign US Masses with No Enhancement on MRI?
    Eur Radiol. 2021;31:975-982.
    PubMed         Abstract available

  33. FROELICH MF, Kaiser CG
    Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
    Eur Radiol. 2021;31:967-974.
    PubMed         Abstract available

  34. LIN X, Jia M, Zhou X, Bao L, et al
    The diagnostic performance of automated versus handheld breast ultrasound and mammography in symptomatic outpatient women: a multicenter, cross-sectional study in China.
    Eur Radiol. 2021;31:947-957.
    PubMed         Abstract available

  35. TASKIN F, Kalayci CB, Tuncbilek N, Soydemir E, et al
    The value of MRI contrast enhancement in biopsy decision of suspicious mammographic microcalcifications: a prospective multicenter study.
    Eur Radiol. 2021;31:1718-1726.
    PubMed         Abstract available


    Int J Cancer

  36. TANG SC, Capra CL, Ajebo GH, Meza-Junco J, et al
    Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer.
    Int J Cancer. 2021 Apr 12. doi: 10.1002/ijc.33597.
    PubMed         Abstract available

  37. KHAN SA, Hernandez-Villafuerte KV, Muchadeyi MT, Schlander M, et al
    Cost-effectiveness of risk-based breast cancer screening: A systematic review.
    Int J Cancer. 2021 Apr 12. doi: 10.1002/ijc.33593.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  38. SHUMWAY DA, Motomura A, Griffith KA, Hayman JA, et al
    Patient Perceptions in a Nonblinded Randomized Trial of Radiation Therapy Technologies: A Novel Survey Study Exploring Therapeutic Misconception.
    Int J Radiat Oncol Biol Phys. 2020;108:867-875.
    PubMed         Abstract available

  39. DETAPPE A, Mathieu C, Jin C, Agius MP, et al
    Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1380-1389.
    PubMed         Abstract available

  40. SHI J, Xu K, Keyvanloo A, Udayakumar TS, et al
    A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography With Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1063-1072.
    PubMed         Abstract available

  41. HEPEL JT, Leonard KL, Sha S, Graves TA, et al
    Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
    Int J Radiat Oncol Biol Phys. 2020;108:1143-1149.
    PubMed         Abstract available


    J Clin Oncol

  42. ALVA AS, Mangat PK, Garrett-Mayer E, Halabi S, et al
    Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    J Clin Oncol. 2021 Apr 12:JCO2002923. doi: 10.1200/JCO.20.02923.
    PubMed         Abstract available


    J Surg Oncol

  43. ALTUNDAG K
    Is there any association between a delay in surgery and nodal positivity in the ER-negative Her2 negative breast cancer subgroups?
    J Surg Oncol. 2021 Apr 12. doi: 10.1002/jso.26485.
    PubMed        

  44. KHADER A, Fischer T
    Response to: Is there any association between a delay in surgery and nodal positivity in the ER-negative Her2 negative breast cancer subgroups?
    J Surg Oncol. 2021 Apr 12. doi: 10.1002/jso.26486.
    PubMed        


    Lancet Oncol

  45. HEIL J, Pfob A, Morrow M
    De-escalation of breast and axillary surgery in exceptional responders to neoadjuvant systemic treatment.
    Lancet Oncol. 2021;22:435-436.
    PubMed        

  46. BUCHHOLZ TA
    Increasing the value of radiotherapy in breast cancer.
    Lancet Oncol. 2021 Apr 9. pii: S1470-2045(21)00120.
    PubMed        

  47. ORECCHIA R, Veronesi U, Maisonneuve P, Galimberti VE, et al
    Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.
    Lancet Oncol. 2021 Apr 9. pii: S1470-2045(21)00080.
    PubMed         Abstract available


    Oncogene

  48. TIEDE S, Kalathur RKR, Luond F, von Allmen L, et al
    Multi-color clonal tracking reveals intra-stage proliferative heterogeneity during mammary tumor progression.
    Oncogene. 2021;40:12-27.
    PubMed         Abstract available


    Oncol Rep

  49. GRASSILLI S, Vezzali F, Cairo S, Brugnoli F, et al
    Targeting the Vav1/miR29b axis as a potential approach for treating selected molecular subtypes of triplenegative breast cancer.
    Oncol Rep. 2021;45.
    PubMed         Abstract available

  50. YOU D, Jeong Y, Yoon SY, A Kim S, et al
    Celastrol attenuates the inflammatory response by inhibiting IL1beta expression in triplenegative breast cancer cells.
    Oncol Rep. 2021;45.
    PubMed         Abstract available


    Radiol Imaging Cancer

  51. TU W, Joe BN
    Trainee Perspectives on Breast Imaging Training during COVID-19: Where We Are Now.
    Radiol Imaging Cancer. 2021;3:e210011.
    PubMed        


    Radiology

  52. BAE MS
    Sustainable Benefits of Digital Breast Tomosynthesis Screening.
    Radiology. 2021;298:58-59.
    PubMed        

  53. SCHATTNER E
    High-Quality Mammography: A Step Forward for Women's Health.
    Radiology. 2020 Dec 1:204087. doi: 10.1148/radiol.2020204087.
    PubMed        


    Radiother Oncol

  54. BOERSMA LJ, Verloop J, Voogd AC, Elkhuizen PHM, et al
    Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03).
    Radiother Oncol. 2020;145:201-208.
    PubMed         Abstract available

  55. ALMAHARIQ MF, Quinn TJ, Siddiqui ZA, Thompson AB, et al
    Post-mastectomy radiotherapy is associated with improved overall survival in T3N0 patients who do not receive chemotherapy.
    Radiother Oncol. 2020;145:229-237.
    PubMed         Abstract available

  56. SCHMEEL LC, Koch D, Schmeel FC, Rohner F, et al
    Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
    Radiother Oncol. 2020;146:172-179.
    PubMed         Abstract available

  57. QUIRK S, Grendarova P, Craighead P, Phan T, et al
    Results of the ACCEL trial: Dosimetry in accelerated partial breast irradiation.
    Radiother Oncol. 2020;147:50-55.
    PubMed         Abstract available

  58. MAST ME, Pekelharing JF, Heijenbrok MW, van Klaveren D, et al
    Reduced increase of calcium scores using breath-hold in left-sided whole breast irradiation.
    Radiother Oncol. 2020;149:78-83.
    PubMed         Abstract available

  59. PAGANETTI H, Depauw N, Johnson A, Forman RB, et al
    The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques.
    Radiother Oncol. 2020;149:212-218.
    PubMed         Abstract available

  60. VAN HULLE H, Vakaet V, Bultijnck R, Deseyne P, et al
    Health-related quality of life after accelerated breast irradiation in five fractions: A comparison with fifteen fractions.
    Radiother Oncol. 2020;151:47-55.
    PubMed         Abstract available

  61. BORRAS JM, Font R, Sola J, Macia M, et al
    Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain.
    Radiother Oncol. 2020;151:200-205.
    PubMed         Abstract available

  62. NACHBAR M, Monnich D, Boeke S, Gani C, et al
    Partial breast irradiation with the 1.5 T MR-Linac: First patient treatment and analysis of electron return and stream effects.
    Radiother Oncol. 2020;145:30-35.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: